This week, the Hanoi Medical University in Vietnam will commence a Phase 1 clinical trial targeting a novel, mRNA-based vaccine called ARCT-154. The product is developed by Arcturus…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.